No transfer in a planned ICSI cycle: We cannot overcome some basic rules of human reproduction

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 87, Issue 1, 1999, Pages 3-11

  Ludwig, M ^a   Strik, D ^a   Al Hasani, S ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Failed cycles; ICSI; Kryo TESE; Low responder

Indexed keywords

CLOMIFENE CITRATE; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; INTERMETHOD COMPARISON; INTRACYTOPLASMIC SPERM INJECTION; MALE; OOCYTE; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

EID: 0032847195     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00071-8     Document Type: Review

References (43)

1. Nagy Z, Liu J, Joris H et al. The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod 1995;10:1123-9.
2. Küpker W, Al-Hasani S, Schulze W et al. Morphology in intracytop-lasmic sperm injection: preliminary results. J Assist Reprod Genet 1995;12:621-6.
3. Ludwig M, Al-Hasani S, Küpker W, Bauer O, Diedrich K. A new indication for the intracytoplasmic sperm injection procedure outside a male factor infertility. Eur J Obstet Gynecol Reprod Biol 1996a;75:207-10.
4. Ludwig M, Al-Hasani S, Küpker W, v. Gizycki U, Sturm R, Diedrich K. Einfluß der Gametenmorphologie und anderer Daten der Sterilitätsbehandlung auf den Erfolg der intrazytoplasmatischen Spermieninjektion (ICSI. J Fertil Reprod 1996;6:7-14.
5. Al-Hasani S, Küpker W, Felberbaum R, Diedrich C, Sturm R, Bauer O, Diedrich K. Die intrazytoplasmatische Spermieninjektion unter Verwendung des mini-swim-up. Verfahrens Fertilität 1995;11:111-4.
6. Grimbizis G, Vandervorst M, Camus M, Tournaye H, VanSteirteghem AC, Devroey P. Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers. Hum Reprod 1998;13:884-9.
7. Goldenberg RL, Grodin JM, Rodbard D, Ross GT. Gonadotropins in women with amenorrhea. The use of plasma follicle-stimulating hormone to differentiate women with and without ovarian follicles. Am J Obstet Gynecol 1973;116:1003-12.
8. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-4.
9. Cameron IT, O'Shea FC, Rolland JM, Hughes EG, DeKretsner DM, Healy DL. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. Chin Endocrinol Metab 1988;67:1190-4.
10. Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH, Navot D. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 1995;10:1706-10.
11. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588-93.
12. Abdelmassih R, Sollia S, Moretto M, Acosta AA. Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection. Fertil Steril 1996;65:573-7.
13. Farhi J, Homburg R, Ferber A, Orvieto R, BenRafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure preempting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997;12:241-3.
14. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;67:110-4.
15. Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995;64:382-91.
16. Lim AST, Ho TN, Tsakok MFH. Chromosomes of oocytes failing in-vitro fertilization. Hum Reprod 1995;10:2570-5.
17. Sengoku K, Tamate K, Takuma N, Yoshida T, Goishi K, Ishikawa M. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod 1997;12:474-7.
18. Flaherty SP, Payne D, Swann NJ, Matthews CD. Aetiology of failed and abnormal fertilization after intracytoplasmic sperm injection. Hum Reprod 1995;10:2623-9.
19. Wall MB, Marks K, Smith TA, Gearon CM, Muggleton-Harris AL. Cytogenetic and fluorescent in-situ hybridization chromosomal studies on in-vitro fertilized and intracytoplasmic sperm injected 'failed-fertilized' human oocytes. Hum Reprod 1996;11:2230-8.
20. Kubiak JZ. Mouse oocytes gradually develop the capacity for activation during the metaphase II arrest. Dev Biol 1989;136:537-45.
21. Eppig JJ, Schultz RM, O'Brien M, Chesnel F. Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes. Dev Biol 1994;164:1-9.
22. Asch R, Simerly C, Ord T, Ord V.Aa. Schatten G. The stages at which human fertilization arrests: microtubule and chromosome configurations in inseminated oocytes which failed to complete fertilization and development in humans. Mol Hum Reprod 1995;1:1897-906, see: Hum Reprod 10.
23. Eichenlaub-Ritter U, Schmiady H, Kentenich H, Soewarto D. Recurrent failure in polar body formation and premature chromosome condensation in oocytes from a human patient: indicators of asyndhrony in nuclear and cytoplasmic maturation. Hum Reprod 1995;10:2343-9.
24. Dozortsev D, deSutter P, Dhont M. Damage of the sperm plasma membrane by touching the spermtail with a needle prior to intracytoplasmatic injection. Hum Reprod 1995;9(Suppl):40.
25. Schill T, Al-Hasani S, Küpker W, Diedrich K. Lichtmikroskopische Untersuchung der Zytomorphologie und Zytogenetik an nichifertilisierten Oozyten nach Invitro-Fertilisation und intrazytoplasmatischer Spermiuminjektion. Geburtshilfe Frauenheillc 1998;58:79-87.
26. De Sutter P, Dozortsev D, Qian C, Dhont M. Oocyte morphology does not correlate with fertilization rate and embryl quality after intracytoplasmic sperm injection. Hum Reprod 1996;11:595-7.
27. Staessen C, Van Steirteghem AC. The chromosomal constitution of embryos developing from abnormally fertilized oocytes after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 1997;12:321-7.
28. Liu J, Nagy Z, Joris H et al. Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Hum Reprod 1995;10:2630-6.
29. Mahadevan MM, Trounson AO, Leeton JF. Successful use of human semen cryobanking for in vitro fertilization. Fertil Steril 1983;40:340-3.
30. Hovatta O, Foudila T, Siegberg R, Johansson K, vonSmitten K, Reima I. Pregnancy resulting from intracytoplasmic injection of spermatozoa from a frozen-thawed testicular biopsy specimen. Hum Reprod 1996;11:2472-3.
31. Fischer R, Baukloh V, Naether OGJ, Schulze W, Salzbrunn A, Benson DM. Pregnancy after intracytoplasmic sperm injection of spermatozoa extracted from frozen-thawed testicular biopsy. Hum Reprod 1996;11:2197-9.
32. Salzbrunn A, Benson DM, Holstein AF, Schulze W. A new concept for the extraction of testicular spermatozoa as a tool for assisted fertilization (ICSI). Hum Reprod 1996;11:752-5.
33. Awonuga AO, Nabi A. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation. J Assist Reprod Genet 1997;14:503-7.
34. Suikkari A, MacLachlan V, Koistinen R, Seppala M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril 1996;65:800-5.
35. Hughes SM, Huang ZH, Morris ID, Matson PL, Buck P, Lieberman BA. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization. Hum Reprod 1994;9:13-8.
36. Fisch B, Royburt M, Pinkas H et al. Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills. Isr J Med Sci 1996;32:1172-6.
37. Olivennes F, Righini C, Fanchin R et al. [Ovarian stimulation using a protocol of low dose agonist in patients with an elevated basal FSH]. Contracept Fertil Sex 1996;24:912-6.
38. Simon A, Benshushan A, Shushan A, Zajicek G, Dorembus D, Lewin A, Laufer N. A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization. Hum Reprod 1994;9:1813-7.
39. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-5.
40. Karande VC, Jones GS, Veeck LL, Muasher SJ. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril 1990;53:486-9.
41. Pellicer A, Lightman A, Diamond MP, Russell JB, DeCherney AH. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987;47:812-5.
42. Van Rysselberge M, Puissant F, Barlow P, Lejeune B, Delvigne A, Leroy F. Fertility prognosis in IVF treatment of patients with cancelled cycles. Hum Reprod 1989;4:663-6.
43. Alpüstün S, Al-Hasani S, Diedrich K, Bauer O, Werner A, Krebs D. In-vitro-Fertilisation-Prognostische Fakoren. Geburtsh Frauenheilk 1994;53:351-5.